title: What sentinel node biopsy in patients with melanoma (or patients whose doctors worry that they could have melanoma) might and might not do.
abstract: The sentinel lymph node biopsy has taught us important lessons about the behavior of melanoma and, perhaps, of melanocytic nevi. It is of proven prognostic importance in patients whose diagnosis of melanoma is clear-cut. Sentinel lymph node biopsy is an imperfect prognostic tool, however, and although the morbidity of the procedure is low, completion lymphadenectomy has a high morbidity rate and unproven benefit. In the setting of a borderline lesion, small nodal deposits must be interpreted with caution.
authors.affiliation: Department of Pathology, University of California at San Francisco School of Medicine, 1701 Divisadero Street, Suite 350, San Francisco, CA 94115, USA. philip.leboit@ucsf.edu
authors.forename: Philip E
authors.initials: PE
authors.lastname: LeBoit
mesh_terms: D001291:Attitude of Health Personnel; D001707:Biopsy, Needle; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000473:pathology* / Q000556:secondary*; D009367:Neoplasm Staging; D009508:Nevus, Pigmented / Q000473:pathology*; D010817:Physician-Patient Relations; D010818:Practice Patterns, Physicians'; D011379:Prognosis; D018570:Risk Assessment; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000473:pathology*